Do elevated TPO and thyroglobulin antibodies indicate Hashimoto's thyroiditis and drive progressive thyroid damage leading to hypothyroidism?

An objective, evidence-based assessment of the clinical utility and pathological mechanisms associated with thyroid autoantibodies in Hashimoto’s thyroiditis.

Diagnostic utility and clinical markers

• Diagnostic sensitivity and specificity: Thyroid peroxidase antibodies (TPOAb) are the premier serological marker for Hashimoto’s thyroiditis. Elevated TPOAb is present in approximately 90% to 95% of patients with the condition, yielding a diagnostic specificity of over 90%.
• The role of thyroglobulin antibodies: Thyroglobulin antibodies (TgAb) serve as a valuable secondary or adjunctive marker. While TgAb is less sensitive on its own (present in 50% to 90% of cases), it exhibits a high specificity of 89% to 90% for differentiating Hashimoto’s from non-autoimmune thyroid diseases. Combining both tests ensures that the 5% to 10% of patients who are TPOAb-negative but TgAb-positive are not missed.
• Risk of progression: Longitudinal cohort studies indicate that the presence of high-titer TPOAb is a strong predictor of progression from subclinical to overt hypothyroidism. Patients with positive TPOAb experience an annual progression rate of 1.5% to 4.3% (and up to 7% when combined with elevated baseline thyroid-stimulating hormone (TSH)).

Immunological mechanisms of damage

• Antigen targeting: TPOAb and TgAb target critical enzymatic and structural components within the thyroid follicles. The resulting autoantibody-antigen binding forms localized immune complexes on the follicular cell surface.
• Cellular destruction: These immune complexes activate the complement cascade and drive antibody-dependent cell-mediated cytotoxicity (ADCC). Natural killer (NK) cells and macrophages are recruited to the thyroid parenchyma, releasing perforins and granzymes that induce thyrocyte injury.
• Apoptosis and follicular atrophy: Local inflammatory cytokines (such as IFN-γ and TNF-α) upregulate death receptors (like Fas/FasL) on thyrocytes. This triggers cascade-mediated apoptosis, leading to progressive lymphocytic infiltration, follicular atrophy, and the replacement of functional parenchyma with fibrotic tissue. On clinical ultrasound, this tissue damage correlates with diffuse thyroid hypoechogenicity.
• Hormonal failure: Because thyrocytes are progressively destroyed, the thyroid gland loses its functional capacity to synthesize and secrete thyroxine ($T_4$) and triiodothyronine ($T_3$), culminating in clinical hypothyroidism.

Bottom line

Elevated TPOAb and TgAb are highly sensitive and specific diagnostic markers for autoimmune thyroiditis (Hashimoto's). Rather than being merely passive markers, these antibodies are active participants in complement-mediated and cell-mediated thyrocyte destruction, resulting in progressive thyroid follicular damage, parenchymal atrophy, and ultimately, a permanent loss of hormone-producing capacity.